Low-grade glial tumors: are they all the same?

Area of Science:

• Pediatric neuro-oncology
• Neurosurgery
• Pathology

Background:

• Low-grade gliomas are the most common pediatric supratentorial brain tumors.
• This category includes diverse pathologies, necessitating refined treatment strategies.
• Advances in immunohistochemistry and classification have improved diagnostic accuracy.

Purpose of the Study:

• To review treatment and outcomes for pediatric low-grade gliomas.
• To determine if different pathologies require distinct therapeutic approaches.
• To synthesize current evidence on managing these diverse tumors.

Main Methods:

• Systematic review of published literature on pediatric low-grade glioma treatment and outcomes.
• Analysis of treatment strategies based on specific pathological diagnoses.
• Evaluation of outcomes following surgical resection and adjuvant therapies.

Main Results:

• Complete surgical resection is the primary treatment for most low-grade gliomas and recurrences.
• Adjuvant therapies are used for unresectable tumors or recurrences.
• Grade II astrocytomas may benefit from more aggressive upfront treatment.
• Radiation is for older children; chemotherapy is preferred for younger children.

Conclusions:

• Treatment for pediatric low-grade gliomas is largely standardized, focusing on surgical resection.
• Pathology-specific treatment variations are limited, with grade II astrocytomas being a potential exception.
• Further research is needed on adjuvant therapies, especially radiosurgery, in pediatric populations.